4//SEC Filing
SAHA SAURABH 4
Accession 0001847903-25-000027
CIK 0001847903other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:56 PM ET
Size
8.3 KB
Accession
0001847903-25-000027
Insider Transaction Report
Form 4
SAHA SAURABH
DirectorChief Executive Officer
Transactions
- Award
Share Option (right to buy)
2025-02-03+900,000→ 900,000 totalExercise: $16.90Exp: 2035-02-03→ Ordinary Shares (900,000 underlying) - Tax Payment
Ordinary Shares
2025-02-01$16.92/sh−43,381$734,007→ 386,017 total
Holdings
- 38,000(indirect: By Trust)
Ordinary Shares
Footnotes (4)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.
- [F3]These shares are held directly in a trust, for which the Reporting Person and his spouse serve as trustees.
- [F4]1/48th of the shares subject to such option shall vest and become exercisable in equal monthly installments with the first installment vesting on March 3, 2025.
Documents
Issuer
Centessa Pharmaceuticals plc
CIK 0001847903
Entity typeother
Related Parties
1- filerCIK 0001861926
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 4:56 PM ET
- Size
- 8.3 KB